Wildon Farwell's most recent trade in Dyne Therapeutics Inc was a trade of 2,060 Common Stock done at an average price of $45.0 . Disclosure was reported to the exchange on Aug. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 19 Aug 2024 | 2,060 | 143,483 | - | 45.0 | 92,721 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 19 Aug 2024 | 261 | 143,222 | - | 46 | 12,006 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 11 Jun 2024 | 1,628 | 146,551 | - | 31.3 | 50,908 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 11 Jun 2024 | 1,008 | 145,543 | - | 31.3 | 31,520 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 16 May 2024 | 1,956 | 148,604 | - | 28.2 | 55,159 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 16 May 2024 | 425 | 148,179 | - | 28.6 | 12,151 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 11 Mar 2024 | 1,585 | 151,590 | - | 25.7 | 40,735 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 11 Mar 2024 | 1,030 | 150,560 | - | 25.6 | 26,347 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 07 Mar 2024 | 8,364 | 154,732 | - | 25.8 | 215,791 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 07 Mar 2024 | 1,557 | 153,175 | - | 26.2 | 40,793 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 28 Feb 2024 | 407 | 163,096 | - | 25 | 10,175 | Common Stock | |
| Dyne Therapeutics Inc | Farwell Wildon | Chief Medical Officer | 12 Feb 2024 | 5,493 | 163,503 | - | 25.1 | 137,710 | Common Stock | |
| Dyne Therapeutics Inc | Farwell Wildon | Chief Medical Officer | 26 Jan 2024 | 100 | 168,996 | - | 25 | 2,500 | Common Stock | |
| Dyne Therapeutics Inc | Farwell Wildon | Chief Medical Officer | 11 Dec 2023 | 1,688 | 170,074 | - | 10.7 | 18,095 | Common Stock | |
| Dyne Therapeutics Inc | Farwell Wildon | Chief Medical Officer | 11 Dec 2023 | 978 | 169,096 | - | 10.6 | 10,318 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 15 Nov 2023 | 82,512 | 171,762 | - | 0 | Common Stock | ||
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 15 Nov 2023 | 32,131 | 32,131 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 12 Sep 2023 | 1,707 | 89,250 | - | 10.4 | 17,770 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 13 Jun 2023 | 1,698 | 90,957 | - | 12.4 | 21,106 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 14 Mar 2023 | 7,441 | 92,655 | - | 13.3 | 99,189 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 09 Dec 2022 | 56,000 | 56,000 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 09 Dec 2022 | 36,000 | 100,724 | - | 0 | Common Stock | ||
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 09 Dec 2022 | 628 | 100,096 | - | 10.9 | 6,826 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 15 Sep 2022 | 658 | 64,724 | - | 14.1 | 9,245 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 14 Jun 2022 | 668 | 65,382 | - | 5.0 | 3,307 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 11 Mar 2022 | 640 | 66,050 | - | 8.7 | 5,587 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 02 Mar 2022 | 5,617 | 66,690 | - | 8.6 | 48,082 | Common Stock | |
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 10 Dec 2021 | 67,935 | 67,935 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 10 Dec 2021 | 22,307 | 72,307 | - | 0 | Common Stock | ||
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 02 Mar 2021 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Wildon Farwell | Chief Medical Officer | 02 Mar 2021 | 50,000 | 50,000 | - | 0 | Common Stock |